feed,title,long_url,short_url
Benzinga,Immune Disease-Focused Alumis Raises $250M In Downsized Initial Public Offering,https://benzinga.com/general/biotech/24/06/39555241/immune-disease-focused-alumis-raises-250m-in-downsized-initial-public-offering,https://da.gd/DrRrP
